Abintus Bio
PrivateLast Round
Series B
Aug 15, 2022
Total Funding Raised
$15.65M
Company Overview
Abintus Bio operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series B round in August 2022.
Abintus Bio is a biotechnology company that develops in vivo genetic medicines designed to reprogram a patient's immune cells directly within the body.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abintus Bio Comparables
Compare Abintus Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alaya.bio | 87% | |
| Eli Lilly and Company | 83% | |
| Umoja Biopharma | 78% |
For institutional investors. Book with your work email.
Abintus Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 15, 2022 | ||||
| Seed | Apr 22, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Abintus Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Skyviews Life Science | Series B |
| Tech Coast Angels | Series B |
| Leukemia & Lymphoma Society | Series B |
| SeedFolio | Series B |
| BioBrit | Series B |
| The Leukemia & Lymphoma Society (LLS) Therapy Acceleration Program (TAP) | Seed |
| Takeda Ventures | Seed, Series B |
For institutional investors. Book with your work email.
Abintus Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abintus Bio's valuation, stock price, and market status.
Is Abintus Bio a public or private company?
Abintus Bio is a private company.
What is the current stock price of Abintus Bio?
Abintus Bio is a private company, so its shares have no public market price. Caplight tracks Abintus Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abintus Bio worth (valuation)?
Valuation information for Abintus Bio is not publicly available.
Can I buy Abintus Bio stock?
Abintus Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abintus Bio's last funding round?
Abintus Bio's most recent funding round was Series B on August 15, 2022.
Who are the main investors in Abintus Bio?
Key investors in Abintus Bio include Skyviews Life Science, Tech Coast Angels, Leukemia & Lymphoma Society, SeedFolio, BioBrit.
Will Abintus Bio IPO soon?
No public IPO plans have been announced for Abintus Bio.
How can I track Abintus Bio secondary market activity?
Caplight tracks bids, offers, and trades in Abintus Bio's shares on secondary markets.